AllergoEye

A cloud-based, AI-powered online visual field testing platform for glaucoma detection and monitoring. The platform enables hospital-grade visual field testing on standard computers or tablets without requiring specialized hardware. It uses AI webcam monitoring to track head position and gaze, generates detailed visual field maps comparing sensitivity to age-matched normal data, and is accessible via web browsers for convenient testing in clinical and remote settings.

Artificial intelligence-driven diagnostic system that analyzes visual field test data to detect glaucomatous changes and assess disease progression. The platform automatically interprets test results and provides clinical assessment outputs for ophthalmologists.

CheckEye is a digital eye screening service that detects retinal changes in early stages using artificial intelligence. A photograph of the eye is taken at a nearby pharmacy or partner health center, and the image is analyzed in the cloud by AI to identify early signs of retinal changes. Results are provided immediately after the screening in an easy-to-understand report. The procedure is painless, contactless, requires no appointment, and takes only a few minutes.

A comprehensive portable eye screening kit that combines multiple handheld devices for point-of-care eye health assessment. The kit integrates on-the-edge AI retinal imaging capabilities for non-invasive evaluation of systemic and retinal health.

All in One Tearscope system for non-invasive diagnosis and comprehensive evaluation of dry eye disease. Integrates EASYTEAR VIEW+ and HDWcam imaging technology to assess lacrimal condition and tear film characteristics in clinical settings.

All-in-one tearscope system for non-invasive assessment and diagnosis of dry eye disease. Combines imaging and software analysis to evaluate tear film quality, quantity, and ocular surface condition in a single diagnostic platform.

Integrated ocular surface evaluation and treatment device for dry eye syndrome diagnosis. Combines diagnostic imaging with therapeutic capabilities. Automated analysis for standardized dry eye assessment.

AI-powered platform for early detection of retinal changes and diabetic retinopathy. Analyzes fundus photographs to identify pathological changes at early stages before symptom onset. Results are generated within minutes and reviewed by medical professionals.

AI-powered platform for early detection of retinal changes and chronic eye disease via fundus imaging analysis. Enables rapid, non-invasive screening for diabetic retinopathy and other retinal pathology by analyzing fundus photographs. Supports preventive ophthalmology and patient risk stratification in primary care and community settings.

A portable non-mydriatic retinograph integrated into a smartphone that enables high-quality retinal examinations without pupil dilation. The device captures color, red-free, and anterior segment images with a 45-degree field of view and can perform panoramic imaging up to 120 degrees. It features automatic focus (-20D to +20D), works with minimum 3mm pupil size, and allows examinations in less than 1 minute with minimal training. Images are captured in JPEG, PDF, and DICOM formats and automatically integrate with EyerCloud for telemedicine capabilities.

An eye health self-diagnosing kiosk that provides advanced digital eye care solutions for managing eye health. It features AI-powered eye health self-diagnosis algorithms that detect facial features and eye positioning, supports various eye health charts including macular degeneration, near vision, and presbyopia testing, and offers adjustable height design for comfortable use in different environments. The kiosk provides clear display imaging under various lighting conditions for accurate examination results.

AIRDOC is an AI-powered retinal imaging system that performs automated screening and assessment of systemic disease risk markers. The device analyzes retinal photographs to detect diabetic retinopathy, hypertension indicators, and cardiovascular risk factors, enabling early intervention in primary care and screening programs.